• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Life Sciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 68121.0
  • ISIN : INE570L01029
756.95 40 (5.62%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    711.95

  • Today’s High

    784.40

  • Open

    720.00

  • Perv Close

    716.65

  • 52W Low

    636.10

  • 52W High

    808.80

Key Indicators

  • P/E(TTM)

    91.11

  • Mar.Cap (₹Cr.)

    15,776.84

  • Div & Yield %

    0.00

  • Book Value(₹)

    103.99

  • Debt-Equity Ratio

    5.62

  • AGM Date

    30-May-2025

  • EPS

    8.32

  • P/E Ratio

    91.11

Financials Ratios

  • Debt-Equity Ratio

    1.00

  • Mar.Cap (₹Cr.)

    15,776.84

  • RONW (%)

    8.89

  • ROCE (%)

    10.46

Score Board

  • Equity (₹ in Cr.)

    20.84

  • BV (₹)

    104.00

  • Sales( ₹ in Cr.)

    1,642.05

  • NP (in Cr.)

    173.46

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    14.40

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    15,798.72

  • 52 Week High

    808.80

  • 52 Week Low

    636.10

  • Price BSE

    758.0

  • Price NSE

    757.00

  • Market Capital( in Cr.)

    15,798.72

  • P/C Ratio

    52.80

  • P/E Ratio

    91.10

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,418.68 1,157.40 841.02 751.47 725.36 695.11
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,418.68 1,157.40 841.02 751.47 725.36 695.11
Other Income 29.33 27.96 28.15 27.29 17.84 5.63
Stock Adjustments -23.80 4.59 2.83 16.50 5.51 -0.58
Total Income 1,424.21 1,189.95 872.00 795.26 748.71 700.16
EXPENDITURE :            
Raw Materials 408.78 413.12 251.14 232.69 207.72 188.22
Power and Fuel Cost 49.49 43.73 31.86 27.25 27.04 25.36
Employee Cost 430.63 353.76 263.37 203.64 202.50 197.18
Other Manufacturing Expenses 84.73 90.06 78.21 50.32 48.82 46.81
Selling and Administration Expenses 117.15 84.16 84.59 85.45 67.36 54.53
Miscellaneous Expenses 16.06 10.29 9.79 4.44 7.57 7.75
Employee Benefit Expenses 430.63 353.76 263.37 203.64 202.50 197.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,106.84 995.11 718.97 603.79 561.01 519.85
Operating Profit 317.37 194.84 153.03 191.46 187.70 180.30
Interest 81.15 74.38 50.98 32.11 21.26 23.78
Gross Profit 236.22 120.46 102.05 159.35 166.44 156.52
Depreciation 107.21 87.77 79.70 71.77 52.36 44.26
Profit Before Tax 129.01 32.69 22.35 87.58 114.08 112.26
Current Tax 7.97 10.73 9.37 3.73 20.48 30.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 25.81 -2.28 -2.70 18.55 13.47 9.37
Reported Net Profit 95.23 24.24 15.68 65.30 80.14 72.90
Extraordinary Items 0.01 -0.38 11.31 0.00 0.00 0.02
Adjusted Net Profit 95.22 24.62 4.37 65.30 80.14 72.88
Adjustment below Net Profit 1.08 2.39 0.00 0.83 0.81 -0.28
P & L Balance brought forward 497.75 478.02 461.76 394.23 314.93 232.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 6.90 -0.58 -0.21 1.65 -9.94
P & L Balance carried down 594.05 497.75 478.02 460.57 394.23 314.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 383.30 396.30 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 38.33 39.63 0.00 0.00 0.00
Earnings Per Share-Unit Curr 53.92 13.76 8.93 36.65 48.92 44.54
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 572.37 517.79 507.50 486.92 484.05 437.47
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    35.17%

  • Public Share Holding

    64.83%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 3,521,560 3,521,560.00 3,521,560 3,521,560
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,521,560 1.69 3,521,560 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,199,905 5.37 11,199,905 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 58,573,210 28.10 58,573,210 6
Others 0 0.00 0 0
Sub Total 69,773,115 33.48 69,773,115 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 25,760,797 12.36 25,760,797 73
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,728,419 1.31 2,728,419 7
Mutual Funds / UTI 24,042,959 11.54 24,042,959 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 862,176 0.41 862,176 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 53,394,351 25.62 53,394,351 104
2] Non Institution
Bodies Corporate 641,909 0.31 641,909 111
Clearing Members 97 0.00 97 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,424,624 3.56 7,417,624 947
Foreign Non Institution Other 55,688,396 26.72 55,688,396 2
Hindu Undivided Families 274,760 0.13 274,760 4,584
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,254,419 4.44 9,254,419 13
Individuals holding nominal share capital up to Rs. 1 lakh 6,771,755 3.25 6,766,755 134,900
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,669,403 0.80 1,669,403 2
Others 0 0.00 0 0
Sub Total 81,725,363 39.21 81,713,363 140,561
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 208,414,389 100.00 208,402,389 140,677

Company Background

Sai Life Sciences LtdPharmaceuticals - Indian - Formulations

  • Sai Life Sciences Ltd
  • BSE Code : 68121.0
  • ISIN : INE570L01029

  • Incorporation Year

    1999

  • Registered Office

    Plot #.DS-7 IKP Knowledge Park
    Turkapally (V) Shameerpet Md, Hyderabad,
    Telangana-500078

  • Telephone

    +91 40 6815 6000

  • FAX

  • Chairman

    Ranga Raju Kanumuri

  • Managing Director

    Krishnamraju Kanumuri

  • Company Secretary

    Runa Karan

  • Auditor

    BSR & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sai Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Life 758.00 1,448.01 1,418.68 91.11 11.36
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92